{"id":7870,"date":"2025-05-13T18:24:20","date_gmt":"2025-05-13T18:24:20","guid":{"rendered":"https:\/\/neuropediatoolkit.org\/?p=7870"},"modified":"2026-11-01T07:32:23","modified_gmt":"2026-11-01T07:32:23","slug":"mogad","status":"publish","type":"post","link":"https:\/\/neuropediatoolkit.org\/pt\/mogad\/","title":{"rendered":"MOGAD"},"content":{"rendered":"<h2 class=\"wp-block-heading\">MOGAD: Enfermedad por anticuerpos contra MOG<\/h2>\n\n<p class=\"wp-block-paragraph\">MOGAD es una enfermedad inflamatoria desmielinizante del SNC causada por anticuerpos contra la glicoprote\u00edna oligodendrocitaria de la mielina (MOG). Es una entidad autoinmune distinta de la esclerosis m\u00faltiple, con patr\u00f3n cl\u00ednico y serol\u00f3gico caracter\u00edstico.<\/p>\n\n\n<h3 class=\"wp-block-heading\">Manifestaciones Cl\u00ednicas Principales<\/h3>\n\n<ul class=\"wp-block-list\"><li><strong>Neuritis \u00f3ptica bilateral<\/strong>: frecuente en ni\u00f1os\/adolescentes; dolor ocular, edema de papila, p\u00e9rdida visual aguda. Puede preceder otras formas.<\/li><li><strong>Mielitis transversa<\/strong>: debilidad motora, alteraciones sensitivas, disfunci\u00f3n vesical. Lesiones en m\u00e9dula espinal en RM.<\/li><li><strong>Encefalomielitis aguda diseminada (ADEM)<\/strong>: presentaci\u00f3n aguda con fiebre, trastornos neurol\u00f3gicos, lesiones multifocales en cerebro y m\u00e9dula espinal.<\/li><\/ul>\n\n\n\n\n<p class=\"wp-block-paragraph\">Las tres manifestaciones son frecuentes en ni\u00f1os, y la presencia de anticuerpos anti-MOG es clave para el diagn\u00f3stico diferencial.<\/p>\n\n\n<h3 class=\"wp-block-heading\">Diagn\u00f3stico y Confirmaci\u00f3n<\/h3>\n\n<ul class=\"wp-block-list\"><li>Prueba serol\u00f3gica positiva para <strong>anticuerpos anti-MOG<\/strong> (prueba de inmunofluorescencia o ELISA)<\/li><li>RM de cr\u00e1neo y m\u00e9dula espinal: lesiones inflamatorias en zonas espec\u00edficas (\u00f3pticas, m\u00e9dula)<\/li><li>Excluir otras causas: esclerosis m\u00faltiple, SLE, infecciones virales<\/li><\/ul>\n\n\n<div id=\"wp-block-themeisle-blocks-accordion-8fa3b81e\" class=\"wp-block-themeisle-blocks-accordion exclusive\">\n<details class=\"wp-block-themeisle-blocks-accordion-item\"><summary class=\"wp-block-themeisle-blocks-accordion-item__title\"><div>Detalles clave de las fuentes<\/div><\/summary><div class=\"wp-block-themeisle-blocks-accordion-item__content\"><p class=\"wp-block-paragraph\"><strong>Referencias claves:<\/strong> <br>\u2022 Mader et al., <em>Neurology<\/em> 2022: Anti-MOG positividad en >90% de casos con neuritis \u00f3ptica bilateral y ADEM en ni\u00f1os. <br>\u2022 Pache et al., <em>Brain<\/em> 2023: MOGAD presenta mejor pron\u00f3stico que esclerosis m\u00faltiple, con frecuentes remisiones tras tratamiento.<\/p>\n\n<\/details><\/div><\/details>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">El manejo temprano con esteroides y, si necesario, inmunoglobulinas o terapia biol\u00f3gica, mejora significativamente el pron\u00f3stico.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Claves finales:<\/strong> <br>\u2022 Considerar MOGAD en ni\u00f1os con neuritis \u00f3ptica bilateral, ADEM o mielitis transversa. <br>\u2022 Confirmar con prueba espec\u00edfica para anticuerpos anti-MOG. <br>\u2022 Evitar diagn\u00f3stico err\u00f3neo como esclerosis m\u00faltiple.<\/p>","protected":false},"excerpt":{"rendered":"<p>MOGAD: Enfermedad por anticuerpos contra MOG MOGAD es una enfermedad inflamatoria desmielinizante del SNC causada por anticuerpos contra la glicoprote\u00edna oligodendrocitaria de la mielina (MOG). Es una entidad autoinmune distinta de la esclerosis m\u00faltiple, con patr\u00f3n cl\u00ednico y serol\u00f3gico caracter\u00edstico. Manifestaciones Cl\u00ednicas Principales Neuritis \u00f3ptica bilateral: frecuente en ni\u00f1os\/adolescentes; dolor ocular, edema de papila, p\u00e9rdida &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/neuropediatoolkit.org\/pt\/mogad\/\" class=\"more-link\">Continue lendo<span class=\"screen-reader-text\"> \u00abMOGAD\u00bb<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":7871,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7870","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","entry"],"_links":{"self":[{"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/posts\/7870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/comments?post=7870"}],"version-history":[{"count":7,"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/posts\/7870\/revisions"}],"predecessor-version":[{"id":8994,"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/posts\/7870\/revisions\/8994"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/media\/7871"}],"wp:attachment":[{"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/media?parent=7870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/categories?post=7870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/pt\/wp-json\/wp\/v2\/tags?post=7870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}